<p>Retinoblastoma (Rb) is a deadly childhood eye cancer that is classically initiated by inactivation of the RB1 tumor suppressor. Clinical management continues to rely on nonspecific chemotherapeutic agents that are associated with treatment resistance and toxicity. Here, we analyzed whole exomes from primary Rb tumors to identify novel Rb dependencies. Several recurrent genomic aberrations implicate estrogen-related receptor gamma (ESRRG) in Rb pathogenesis. ESRRG is an essential mediator of hypoxic adaptation and cell survival in retinoblastoma, representing a promising new therapeutic target.<br></p>

RB1 Loss Triggers Dependence on ESRRG in Retinoblastoma

Retinoblastoma study with WXS data on dbGaP (31 participants)

RB1 Loss Triggers Dependence on ESRRG in Retinoblastoma

Description

Applying For Access

Summary